Eli Lilly 2009 Annual Report Download - page 54

Download and view the complete annual report

Please find page 54 of the 2009 Eli Lilly annual report below. You can navigate through the pages in the report by either clicking on the pages listed below, or by using the keyword search tool below to find specific information within the annual report.

Page out of 172

  • 1
  • 2
  • 3
  • 4
  • 5
  • 6
  • 7
  • 8
  • 9
  • 10
  • 11
  • 12
  • 13
  • 14
  • 15
  • 16
  • 17
  • 18
  • 19
  • 20
  • 21
  • 22
  • 23
  • 24
  • 25
  • 26
  • 27
  • 28
  • 29
  • 30
  • 31
  • 32
  • 33
  • 34
  • 35
  • 36
  • 37
  • 38
  • 39
  • 40
  • 41
  • 42
  • 43
  • 44
  • 45
  • 46
  • 47
  • 48
  • 49
  • 50
  • 51
  • 52
  • 53
  • 54
  • 55
  • 56
  • 57
  • 58
  • 59
  • 60
  • 61
  • 62
  • 63
  • 64
  • 65
  • 66
  • 67
  • 68
  • 69
  • 70
  • 71
  • 72
  • 73
  • 74
  • 75
  • 76
  • 77
  • 78
  • 79
  • 80
  • 81
  • 82
  • 83
  • 84
  • 85
  • 86
  • 87
  • 88
  • 89
  • 90
  • 91
  • 92
  • 93
  • 94
  • 95
  • 96
  • 97
  • 98
  • 99
  • 100
  • 101
  • 102
  • 103
  • 104
  • 105
  • 106
  • 107
  • 108
  • 109
  • 110
  • 111
  • 112
  • 113
  • 114
  • 115
  • 116
  • 117
  • 118
  • 119
  • 120
  • 121
  • 122
  • 123
  • 124
  • 125
  • 126
  • 127
  • 128
  • 129
  • 130
  • 131
  • 132
  • 133
  • 134
  • 135
  • 136
  • 137
  • 138
  • 139
  • 140
  • 141
  • 142
  • 143
  • 144
  • 145
  • 146
  • 147
  • 148
  • 149
  • 150
  • 151
  • 152
  • 153
  • 154
  • 155
  • 156
  • 157
  • 158
  • 159
  • 160
  • 161
  • 162
  • 163
  • 164
  • 165
  • 166
  • 167
  • 168
  • 169
  • 170
  • 171
  • 172

PERFORMANCE GRAPH
This graph compares the return on Lilly stock with that of the Standard & Poor’s 500 Stock Index and our
peer group for the years 2005 through 2009. The graph assumes that, on December 31, 2004, a person
invested $100 each in Lilly stock, the S&P 500 Stock Index, and the peer group’s common stock. The
graph measures total shareholder return, which takes into account both stock price and dividends. It
assumes that dividends paid by a company are reinvested in that company’s stock.
Value of $100 Invested on Last Business Day of 2004
Comparison of Five-Year Cumulative Total Return Among Lilly, S&P 500 Stock Index, Peer Group
1
, and
Peer Group (Previous)
2
$0.00
$20.00
$40.00
$60.00
$80.00
$100.00
$120.00
$140.00
Dec-09Dec-08Dec-07Dec-06Dec-05Dec-04
S&P 500Peer Group (Previous)Peer GroupLilly
Lilly Peer Group Peer Group
(Previous) S&P 500
Dec-04 $100.00 $100.00 $100.00 $100.00
Dec-05 $102.53 $103.28 $ 99.29 $104.90
Dec-06 $ 97.18 $116.07 $112.42 $121.43
Dec-07 $102.70 $116.21 $114.87 $128.09
Dec-08 $ 80.74 $ 99.55 $ 97.59 $ 80.77
Dec-09 $ 75.80 $113.46 $108.78 $102.08
1
We constructed the peer group as the industry index for this graph. It comprises the ten companies in the
pharmaceutical industry that we used to benchmark 2009 compensation of executive officers: Abbott Laboratories;
Amgen Inc.; AstraZeneca PLC; Bristol-Myers Squibb Company; GlaxoSmithKline plc; Johnson & Johnson; Merck & Co.,
Inc.; Novartis AG.; Pfizer Inc.; and Sanofi-Aventis.
2
Due to changes in the pharmaceutical industry, the peer group used to benchmark 2008 compensation of executive
officers was revised, with the previous peer group consisting of the following companies: Abbott Laboratories; Amgen
Inc.; Bristol-Myers Squibb Company; GlaxoSmithKline plc; Johnson & Johnson; Merck & Co., Inc.; Pfizer Inc.;
Schering-Plough Corporation; and Wyeth. The Peer Group (Previous) excludes Schering-Plough Corporation and Wyeth
as both companies were acquired during 2009.
42
FORM 10-K